Government Relations

ACNM Government Relations Areas of Focus

Representation of nuclear physician's interests before Congress and federal regulatory bodies
Monthly government affairs reports
Electronic issue alerts
FDA activities with respect to review and approval of radiopharmaceuticals
NRC quality assurance activities
Efforts to influence federal funding for nuclear medicine research
Educational and training requirements for NRC licensure
Nuclear medicine political action committee

Breaking News

ACNM relays concern about Executive Order 13769, suspending the entry of alien nationals from seven countries, to the US President. Read ACNM's letter to the president.

ACNM responds to the US Nuclear Regulatory Commission Draft Program-Specific Guidance About Medical Use Licenses (NRC-2016-0122), questioning the utility of the proposed revision. Read ACNM's response.

Latest News

July 17, 2019 — Bipartisan Group Moves to Expand Access to Diagnostic Radiopharmaceuticals
On July 16, a bipartisan group introduced the Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (HR 3772). The bill would expand patient access to highly targeted, precision diagnostic radiopharmaceuticals that evaluate conditions such as Alzheimer’s disease, Parkinson’s disease, and some cancers—allowing patients to get the right treatment faster and saving taxpayers money.
June 5, 2019 — USP Publishes General Chapter <825> Effective December 1, 2019
On June 1, the U.S. Pharmacopeia (USP) published General Chapter <825> Radiopharmaceuticals – Preparation, Compounding, Dispensing, and Repackaging. This General Chapter provides uniform minimum standards for the preparation, compounding, dispensing, and repackaging of sterile and non-sterile radiopharmaceuticals for humans and animals that occur as part of state-licensed activities.
May 29, 2019 — NRC Proposes Reductions in Training and Experience Requirements for Administering Radiopharmaceuticals
The NRC has proposed changes that could reduce the training and experience currently required to administer radiopharmaceuticals for which a written directive is required. SNMMI believes these changes would compromise the safety of patients, their caregivers, and family members. Read more.
May 15, 2019 — SNMMI's Voice Heard in Medicare Local Coverage Decision
In the summer of 2018, SNMMI submitted comments to a Medicare Administrative Contractor offering support for SPECT imaging with DaTscan.
April 30, 2019 — SNMMI Member Hosts Policymakers at Georgetown Hospital
On Thursday April 25th, distinguished SNMMI member Giuseppe Esposito, MD, alongside staff from SNMMI, and MITA hosted congressional staffers at Georgetown Hospital in Washington, DC.

View All Government Relations News »